Heber, M E <br/><br/>
First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.  [electronic resource] 

 -  The American journal of cardiology  Aug 1988 
 - 239-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/0002-9149(88)90219-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensin II--blood<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Blood Pressure--drug effects<br/>Blood Pressure Determination--methods<br/>Bridged Bicyclo Compounds--administration & dosage<br/>Bridged-Ring Compounds--therapeutic use<br/>Clinical Trials as Topic<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Monitoring, Physiologic<br/>Ramipril<br/>Time Factors